(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ENZYME

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ENZYME

ST13

US500000087581719

Class

42

Filing

87581719

Registration

5462974

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

11/27/2025

Trademark type

Word

Nice classes

42

Filing date

08/24/2017

Registration date

05/08/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/04/2023

Last transaction

11/27/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

2016-05-00

First use in commerce

2016-05-00

Drawing code

4

Owner type

16

Owner location

NEW YORK, NY

Examiner

KOVALSKY,LAURA G

Law office

M10

Current location

TMO LAW OFFICE 110

Holders and representatives

Holders

UL HELIUM, LLC
E. C. (pessoa física)
E. C. (pessoa física)

Representatives

Sean Ploen PLOEN LAW FIRM PC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Software as a service (SAAS) services featuring software for managing regulatory submissions and licenses; Software as a service (SAAS) services featuring software for managing and monitoring compliance with industry and governmental lawsregulationsproduct registration rules for medicalmedical devicemedical diagnosticbiopharmaceuticalbiotechnology products; Software as a service (SAAS) services featuring software for auditing and risk management; Software as a service (SAAS) services featuring software for tracking and monitoring regulatory requirements in the fields of medicalmedical devicemedical diagnosticbiopharmaceuticalbiotechnology products for regulatory compliance purposes; Software as a service (SAAS) services featuring software for aiding in the design of medical devicemedical diagnosticbiopharmaceuticalbiotechnology products

Publications

History of USPTO decisions and trademark events.

25 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/26/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/05/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/04/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/04/2023

E815

TEAS SECTION 8 & 15 RECEIVED

06/06/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/08/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/27/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/27/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/27/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/08/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/20/2018

PUBO

PUBLISHED FOR OPPOSITION

02/20/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/31/2018

ALIE

ASSIGNED TO LIE

01/12/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/29/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

12/19/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/19/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

12/19/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/19/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/07/2017

GNRT

NON-FINAL ACTION E-MAILED

12/07/2017

CNRT

NON-FINAL ACTION WRITTEN

12/07/2017

DOCK

ASSIGNED TO EXAMINER

11/30/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/29/2017

NWAP

NEW APPLICATION ENTERED

08/28/2017

Continuous trademark protection

Get notified about every new filing that threatens ENZYME or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.